Literature DB >> 25595038

Bisubstrate inhibitor approach for targeting mitotic kinase Haspin.

Katrin Kestav1, Darja Lavogina, Gerda Raidaru, Apirat Chaikuad, Stefan Knapp, Asko Uri.   

Abstract

During the past decade, the basophilic atypical kinase Haspin has emerged as a key player in mitosis responsible for phosphorylation of Thr3 residue of histone H3. Here, we report the construction of conjugates comprising an aromatic fragment targeted to the ATP-site of Haspin and a peptide mimicking the N-terminus of histone H3. The combination of effective solid phase synthesis procedures and a high throughput binding/displacement assay with fluorescence anisotropy readout afforded the development of inhibitors with remarkable subnanomolar affinity toward Haspin. The selectivity profiles of novel conjugates were established by affinity studies with a model basophilic kinase (catalytic subunit of cAMP-dependent protein kinase) and by a commercial 1-point inhibition assay with 43 protein kinases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25595038     DOI: 10.1021/bc500464r

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  2 in total

1.  Co-crystal structures of the protein kinase haspin with bisubstrate inhibitors.

Authors:  Darja Lavogina; Katrin Kestav; Apirat Chaikuad; Christina Heroven; Stefan Knapp; Asko Uri
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-04-22       Impact factor: 1.056

2.  Anti-Melanoma Activities of Haspin Inhibitor CHR-6494 Deployed as a Single Agent or in a Synergistic Combination with MEK Inhibitor.

Authors:  Lili Han; Peiling Wang; Yang Sun; Sijing Liu; Jun Dai
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.